Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test

NCT01426308 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT01426308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01426308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Lead sponsor
Illumina, Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
November 30, 2011
Enrollment
900 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

post-natal cytogenetics